Please provide your email address to receive an email when new articles are posted on . Subcutaneous implantable cardioverter defibrillators can be extracted safely and feasibly. S-ICD extraction was ...

SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

Though the PRAETORIAN group was technically unable to prove that 8 years was enough to give a subcutaneous implantable cardioverter-defibrillator (ICD) an edge in safety, complication rates helped ...

May 18, 2009 (Boston, Massachusetts) — Early results from a small, randomized clinical trial testing an implantable converter defibrillator (ICD) featuring a totally subcutaneous lead system (Cameron ...

NICE, FRANCE – A longer-term assessment of a new subcutaneous implantable cardioverter defibrillator (ICD) (Boston Scientific) shows that just over 90% of patients are free from complications at two ...

Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator had a high rate of freedom from inappropriate shock at 18 ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...

The Cleveland Clinic announced their team successfully implanted the world's first leadless pacemaker defibrillator system in two patients. Pacemakers provide electrical stimulation to regulate a ...

Cleveland Clinic doctors were the first in the world to successfully implant leadless pacemaker defibrillator systems in two patients as part of a global clinical trial sponsored by Boston Scientific, ...